Cite
HARVARD Citation
Donlon, N. et al. (2020). Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype. Annals of surgery. 272 (5), p. . [Online].